Back
ESC Professional Premium Access

Echocardiographic variables may improve baseline risk prediction of cancer therapy related cardiac dysfunction

Session: Cardio-oncology: predicting adverse effects and prognosis
Topic: Cardio-Oncology
Speaker: Doctor L. Ruane (Brisbane, AU)
Event: ESC Congress 2024

Congress Presentation

Add to my library

Like

About the speaker

Doctor Lorcan Ruane

The Prince Charles Hospital, Brisbane (Australia)
0 follower

9 more presentations in this session

Adverse Myocardial and vascular side effects of Immune Checkpoint Inhibitors: a prospective multimodal cardiovascular assessment (AMICI study)

Speaker: Doctor M. Mirabel (Paris, FR)

Access
Abstract
Slides
Video
Like
Thumbnail

Cardiovascular outcomes in acute coronary syndrome patients with cancer: a statewide population-linkage study

Speaker: Doctor C. Yu (Toronto, CA)

Access
Abstract
Slides
Video
Like
Thumbnail

The CTOX-Score, a clinical risk prediction tool for cardiovascular toxicity secondary to cancer therapies

Speaker: Doctor J. Gonzalez Juanatey (Santiago de Compostela, ES)

Access
Abstract
Slides
Video
Like
Thumbnail

Fibroblast activation in cardio-oncology

Speaker: Doctor K. Loganath (Edinburgh, GB)

Access
Abstract
Slides
Video
Like
Thumbnail

Sodium-glucose co-transporter-2 inhibitors : a potential cardioprotective agent?

Speaker: Doctor T. Georgopoulou (Heraklion, GR)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Cardio-oncology: predicting adverse effects and prognosis

Speakers: Doctor L. Ruane, Doctor M. Mirabel, Doctor C. Yu, Doctor J. Gonzalez Juanatey, Doctor K. Loganath...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources